首页> 外国专利> ANTI-CONVULSION AMINO ACIDS FOR THE TREATMENT OF OBSESSIVE-COMPULSIVE NEUROSIS.

ANTI-CONVULSION AMINO ACIDS FOR THE TREATMENT OF OBSESSIVE-COMPULSIVE NEUROSIS.

机译:抗惊厥性氨基酸治疗难治性神经症。

摘要

Use of a compound of the following formula (I) for the preparation of a medicament for the treatment of obsessive-compulsive neurosis in a mammal: or a pharmaceutically acceptable salt thereof, in which Ar is aryl that is unsubstituted or substituted with at least one electron donor group or an electron extractor group; R1 is alkyl; R3 is alkyl, alkenyl, alkynyl, aryl-alkyl, aryl, halo, heterocyclic, heterocyclic-alkyl, alkyl-heterocyclic, cycloalkyl, cycloalkyl-alkyl, each of which is not substituted or substituted with at least one extracting group of electrons or an electron donor group, or is ZY; Z is O, S, S (O) a, NR4 or PR4; Y is hydrogen, alkyl, aryl, aryl-alkyl, alkenyl, alkynyl, halo, heterocyclic, heterocyclic-alkyl, alkyl-heterocyclic-cycloalkyl, cycloalkyl-alkyl, and Y is unsubstituted or substituted with an electron donor group or a electron extractor group, or 30 ZY, taken together, is NNR4NR5R7, NR4OR5, ONR4R7, OPR4R5, PR4OR5, SNR4R7, NR4SR7, SPR4R5, PR4SR7, NR4PR5R6, PR4NR5R7, NR4C (= O) OR5, SC5 OR5, SC5 OR5, SC5 OR5, SC5 OR5, SC5 OR5, SC5 OR5, SC5 OR5, SC5 (= O) R5 or NR4C (= O) R5, R4, R5 and R6 are, independently, hydrogen, alkyl, aryl, aryl-alkyl, alkenyl, or alkynyl, each being unsubstituted or substituted with an extractor group of electrons or an electron donor group; R7 is hydrogen, alkyl, aryl, aryl-alkyl, alkenyl or alkynyl, each of which may be unsubstituted or substituted with an electron donor group or an electron extractor group, or R7 is COOR8 or COR8, R8 is hydrogen, alkyl or aryl-alkyl, the aryl or alkyl group being optionally substituted with an electron extraction group or an electron donor group; and 45 a is 1-3 in which alkyl contains 1-6 carbon atoms, alkenyl contains 2-6 carbon atoms, alkynyl contains 2-6 carbon atoms, cycloalkyl contains from 3 to 18 5 annular carbon atoms and up to a total of 25 carbon atoms, halo is fluoro, chloro, bromo or iodo, heterocyclic is selected from the group consisting of furyl, thienyl, pyrazolyl, pyrrolyl, imidazolyl, indolyl, thiazolyl, oxazolyl, isothiazolyl, isoxazolyl, piperidyl, pyrrolinyl , piperazinyl, quinolyl, triazolyl, tetrazolyl, isoquinolyl, benzofuryl, benzothienyl, morpholinyl, benzoxazolyl, tetrahydrofuryl, pyranyl, indazolyl, purinyl, 10 indolinyl, pyrazolindinyl, imidazolinyl, imadazolindinyl, pyrrolidinyl, furazanyl, N-methylindolyl, methylfuryl, pyridazinyl, pyrimidinyl, methylpyrrolyl, pyrazinyl, pyridyl, epoxy, aziridino, oxetanyl, azetidinyl and the N-oxides of the nitrogen-containing heterocyclics listed hereinabove having a Annular nitrogen atom, 15 and electron donor and electron extractor groups are halo, nitro, alkanoyl, formyl, arylalkanoyl, aryloyl, carboxyl, carbalkoxy, carboxamido, cyano, aryl, trifluoromethyl, aryloxy, sulfonyl, sulfoxide, heterocyclic, guanidine , quaternary ammonium, alkenyl, alkynyl, sulphonium, hydroxy, alkoxy, alkyl, amino, alkylamino, dialkylamino, amino-alkyl, mercapto, alkylthio, or alkyldithium salts. twenty
机译:下式(I)的化合物在制备用于治疗哺乳动物的强迫性神经症的药物中的用途:或其药学上可接受的盐,其中Ar是未被取代或被至少一种取代的芳基电子给体基团或电子提取基团; R1是烷基; R 3是烷基,烯基,炔基,芳基-烷基,芳基,卤素,杂环,杂环-烷基,烷基-杂环,环烷基,环烷基-烷基,它们中的每一个均未被或未被至少一个电子或电子的提取基团取代。电子给体基团,或为ZY; Z为O,S,S(O)a,NR4或PR4; Y是氢,烷基,芳基,芳基烷基,烯基,炔基,卤素,杂环,杂环烷基,烷基-杂环-环烷基,环烷基-烷基,并且Y未被取代或被电子给体基团或电子提取基团取代或30 ZY一起为NNR4NR5R7,NR4OR5,ONR4R7,OPR4R5,PR4OR5,SNR4R7,NR4SR7,SPR4R5,PR4SR7,NR4PR5R6,PR4NR5R7,NR4C(= O)OR5,SC5 OR5,SC5 OR5, SC5 OR5,SC5 OR5,SC5 OR5,SC5(= O)R5或NR4C(= O)R5,R4,R5和R6独立地是氢,烷基,芳基,芳基-烷基,烯基或炔基,各自未被取代或被电子的提取基团或电子给体基团取代;或R 7是氢,烷​​基,芳基,芳基-烷基,烯基或炔基,它们各自可以未被取代或被电子给体基团或电子提取基团取代,或R 7是COOR 8或COR 8,R 8是氢,烷基或芳基-烷基,所述芳基或烷基任选地被电子提取基团或电子给体基团取代; 45a是1-3,其中烷基包含1-6个碳原子,烯基包含2-6个碳原子,炔基包含2-6个碳原子,环烷基包含3至18 5个环状碳原子,最多25个碳原子,卤素为氟,氯,溴或碘,杂环选自呋喃基,噻吩基,吡唑基,吡咯基,咪唑基,吲哚基,噻唑基,恶唑基,异噻唑基,异恶唑基,哌啶基,吡咯烷基,哌嗪基,喹啉基,四唑基,异喹啉基,苯并呋喃基,苯并噻吩基,吗啉基,苯并恶唑基,四氢呋喃基,吡喃基,吲唑基,嘌呤基,10个吲哚基,吡唑啉基,咪唑啉基,咪唑啉基,吡咯烷基吡啶基,呋喃氮基,N-甲基吲哚基,甲基上面列出的具有环状氮原子的环氧基,叠氮基,氧杂环丁烷基,氮杂环丁烷基和氮杂环丁烷基和N-氧化物15且电子给体和电子提取基团是卤素,硝基,烷基酰基,甲酰基,芳基烷酰基,芳酰基,羧基,烷氧基,羧酰胺基,氰基,芳基,三氟甲基,芳氧基,磺酰基,亚砜,杂环,胍,季铵,烯基,炔基,sulph,羟基,烷氧基,烷基,氨基,烷基氨基二烷基,氨基-烷基,巯基,烷硫基或烷基吡啶鎓盐。二十

著录项

  • 公开/公告号ES2348646T3

    专利类型

  • 公开/公告日2010-12-10

    原文格式PDF

  • 申请/专利权人 RESEARCH CORPORATION TECHNOLOGIES INC.;

    申请/专利号ES20060012400T

  • 发明设计人 HARRIS ROBERT H.;

    申请日2001-08-24

  • 分类号A61K31/16;A61K38;A61K31/165;A61K31/195;A61P25/04;A61P25/06;A61P29;C07K5/10;

  • 国家 ES

  • 入库时间 2022-08-21 18:02:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号